Advanced Systemic Mastocytosis: A New Drug On The Horizon?

The Science

Here’s an interesting piece on recent research for a new drug to treat KIT positive patients with advanced systemic mastocytosis and mast cell leukemia. I’ve abridged to highlight the exciting parts: The Food and Drug Administration has approved only one drug, called imatinib, to treat advanced mastocytosis. Imatinib blocks the action of a cellular protein […]

February 21, 2017